MyFinsight
Home
Blog
About
Available For Sale
$568,189K
Net cash provided by
(used in) investing...
$281,260K
(125.91%↑ Y/Y)
Effect of exchange rate
changes on cash, cash...
$315K
(-61.35%↓ Y/Y)
Canceled cashflow
$286,929K
Net change in cash,
cash equivalents and...
-$170,439K
(88.46%↑ Y/Y)
Canceled cashflow
$281,575K
Share-based compensation
$83,342K
(1.42%↑ Y/Y)
Other
-$9,789K
(11.67%↑ Y/Y)
Other liabilities
$7,930K
Accounts payable
$7,109K
(160.53%↑ Y/Y)
Other assets
-$1,868K
Non-cash lease expense
$1,394K
(-28.26%↓ Y/Y)
Depreciation and
amortization
$600K
(-45.36%↓ Y/Y)
Proceeds from exercise of
the companys and...
$76,019K
(152.92%↑ Y/Y)
Repurchase of the companys
common shares
-$1,564K
(-100.75%↓ Y/Y)
Proceeds from issuance of
the companys common...
$635K
Purchases
$286,510K
Purchase of property and
equipment
$419K
(-89.62%↓ Y/Y)
Net cash used in
operating activities
-$270,504K
(-32.35%↓ Y/Y)
Canceled cashflow
$112,032K
Net cash used in
financing activities
-$181,510K
(3.33%↑ Y/Y)
Canceled cashflow
$78,218K
Net loss
-$290,606K
(-6.10%↓ Y/Y)
Change in fair value of
investments
$36,637K
(291.57%↑ Y/Y)
Other current assets
$23,836K
(18721.88%↑ Y/Y)
Accrued expenses
-$13,911K
(44.36%↑ Y/Y)
Income tax payable
-$10,177K
Accretion of discount and
amortization of premium on...
$5,691K
Litigation settlement
receivable
$1,392K
Operating lease
liabilities
-$286K
(40.17%↑ Y/Y)
something is missing
-$208,293K
Taxes paid related to
net settlement of...
$51,435K
(439.60%↑ Y/Y)
Back
Back
Cash Flow
ROIV_BIG copy-svg
Roivant Sciences Ltd. (ROIV)
ROIV_BIG copy-svg
Roivant Sciences Ltd. (ROIV)
source: myfinsight.com